During the last decade, spondyloarthritis (SpA) has increasingly been considered a disease at the crossroads between autoimmunity and autoinflammation. Some patients may even present with autoinflammatory-related manifestations, including fever, hidradenitis suppurativa, other neutrophilic dermatoses, and an unusually high increase in inflammatory markers. Therefore, a subgroup of SpA patients may be identified, and specific details about this cluster need to be investigated. In this regard, the AutoInflammatory Disease Alliance (AIDA) Network has developed a registry primarily aimed at better understanding the autoinflammatory aspects of SpA. The development of this Registry favors the systematic assessment of SpA through the lens of autoinflammation, giving a voice to patients with atypical presentations, and favoring a personalized treatment approach. By supporting research and facilitating the transfer of new evidence to clinical practice, this specific registry has the potential to significantly advance the field of rheumatology and enhance the lives of patients suffering from this complex and multifaceted disease.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11868044 | PMC |
| http://dx.doi.org/10.3389/fmed.2025.1509357 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Efficacy and safety profile of biotechnological agents and Janus kinase inhibitors in VEXAS syndrome: data from the international AIDA Network VEXAS registry.
Front Pharmacol
February 2025
Department of Medical Sciences, Surgery and Neurosciences, Research Center of Systemic Autoinflammatory Diseases and Behçet's Disease Clinic, University of Siena, Siena, Italy.
Background: VEXAS syndrome, a recently identified systemic autoinflammatory disorder, poses new diagnostic and management challenges. Based on experience with other autoinflammatory diseases, anti-interleukin (IL)-1, anti-IL-6, anti-tumor necrosis factor (TNF) biotechnological agents, and Janus kinase inhibitors (JAKis) have been widely employed in VEXAS patients. The aim of this study is to evaluate the global effectiveness and safety of biotechnological agents and JAKis using data from the real-world context.
View Article and Find Full Text PDFDevelopment and implementation of the international AIDA network spondylarthritis registry.
Front Med (Lausanne)
February 2025
Department of Medical Sciences, Surgery and Neurosciences, Research Center of Systemic Autoinflammatory Diseases and Behçet's Disease Clinic, University of Siena, Siena, Italy.
During the last decade, spondyloarthritis (SpA) has increasingly been considered a disease at the crossroads between autoimmunity and autoinflammation. Some patients may even present with autoinflammatory-related manifestations, including fever, hidradenitis suppurativa, other neutrophilic dermatoses, and an unusually high increase in inflammatory markers. Therefore, a subgroup of SpA patients may be identified, and specific details about this cluster need to be investigated.
View Article and Find Full Text PDFSkin cancer detection using dermoscopic images with convolutional neural network.
Sci Rep
March 2025
Artificial Intelligence and Data Analytics (AIDA) Lab, CCIS, Prince Sultan University, Riyadh, 11586, Saudi Arabia.
Skin malignant melanoma is a high-risk tumor with low incidence but high mortality rates. Early detection and treatment are crucial for a cure. Machine learning studies have focused on classifying melanoma tumors, but these methods are cumbersome and fail to extract deeper features.
View Article and Find Full Text PDFReinforcement learning based route optimization model to enhance energy efficiency in internet of vehicles.
Sci Rep
January 2025
Artificial Intelligence and Data Analytics (AIDA) Lab, CCIS Prince Sultan University, 11586, Riyadh, Saudi Arabia.
The Internet of Vehicles (IoV) transforms the automobile industry through connected vehicles with communication infrastructure that improves traffic control, safety and information, and entertainment services. However, some issues remain, like data protection, privacy, compatibility with other protocols and systems, and the availability of stable and continuous connections. Specific problems are related to energy consumption for transmitting information, distributing energy loads across the vehicle's sensors and communication units, and designing energy-efficient approaches to processing received data and making decisions in the context of the IoV environment.
View Article and Find Full Text PDFThe clinical assessment of lung involvement in patients with Still's disease, results from the multicentre international AIDA Network Still's Disease Registry.
Rheumatology (Oxford)
January 2025
Department of Medical Sciences, Surgery and Neurosciences, Research Center of Systemic Autoinflammatory Diseases and Behçet's Disease Clinic, University of Siena, Siena, Italy.
Objectives: To assess the lung involvement in patients with Still's disease, an inflammatory disease assessing both children and adults. To exploit possible associated factors for parenchymal lung involvement in these patients.
Methods: A multicentre observational study was arranged assessing consecutive patients with Still's disease characterized by the lung involvement among those included in the AIDA (AutoInflammatory Disease Alliance) Network Still's Disease Registry.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!